A rapid and simple UPLC method for serum Vancomycin (cas 1404-90-6) determination in pediatric patients undergoing continuous infusion or intermittent infusion of Vancomycin (cas 1404-90-6)
-
Add time:09/04/2019 Source:sciencedirect.com
Vancomycin (cas 1404-90-6) is a glycopeptide antibiotic widely used against Gram-positive bacteria such as methicillin-resistant Staphylococcus aureus and coagulase-negative Staphylococcus. Several studies have found that in adults, continuous infusions of vancomycin showed earlier attainment of desired target drug concentrations and reduced nephrotoxicity relative to intermittent infusion. In the pediatric population, there is no consensus on the best vancomycin infusion method. The present study developed and validated a simple and cost-effective UPLC method to determine serum vancomycin levels in pediatric patients and applied it to the therapeutic drug monitoring of vancomycin in children who were treated with either continuous infusion or intermittent infusion of vancomycin. The sample preparation procedure involves only protein precipitation and filtration, and the UPLC method takes 5 min/sample. The assay was linear from 5 mg/L to 100 mg/L (R2 = 0.999). The precision and accuracy were determined at 4 concentration levels. The intraday variability (%CV) ranged from 1.23% to 6.01% (n = 6), and the interday variability ranged from 3.02% to 9.75% (n = 18). The accuracies were good and ranged from 91.21% to 112.63%. Serum vancomycin was stable at room temperature for 12 h or for 3 freeze/thaw cycles, and the processed sample was stable in an autosampler within 15.5 h.
We also recommend Trading Suppliers and Manufacturers of Vancomycin (cas 1404-90-6). Pls Click Website Link as below: cas 1404-90-6 suppliers
Prev:Original articleLinezolid versus Vancomycin (cas 1404-90-6) cost in the treatment of staphylococcal pneumoniaCoût du linézolide versus Vancomycin (cas 1404-90-6)e dans le traitement des pneumopathies à staphylocoque
Next:Original articleVancomycin (cas 1404-90-6)-associated drug-induced hypersensitivity syndrome) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Population pharmacokinetics of Vancomycin (cas 1404-90-6) in Chinese patients with augmented renal clearance09/10/2019
- Review ArticleSelection pressures of Vancomycin (cas 1404-90-6) powder use in spine surgery: a meta-analysis09/09/2019
- ReviewThe dosing and monitoring of Vancomycin (cas 1404-90-6): what is the best way forward?09/08/2019
- Short reportVancomycin (cas 1404-90-6) use in surrounding patients during critical illness and risk for persistent colonization with Vancomycin (cas 1404-90-6)-resistant Enterococcus09/07/2019
- Vancomycin (cas 1404-90-6) release from biodegradable βTCP-FeAg nanocomposites09/06/2019
- Original articleVancomycin (cas 1404-90-6)-associated drug-induced hypersensitivity syndrome09/05/2019
- Original articleLinezolid versus Vancomycin (cas 1404-90-6) cost in the treatment of staphylococcal pneumoniaCoût du linézolide versus Vancomycin (cas 1404-90-6)e dans le traitement des pneumopathies à staphylocoque09/03/2019
- ReviewVancomycin (cas 1404-90-6)-soaked wrapping of harvested hamstring tendons during anterior cruciate ligament reconstruction. A review of the ‘Vancomycin (cas 1404-90-6) wrap’☆☆☆09/02/2019
- Vancomycin (cas 1404-90-6)-induced Kounis Syndrome09/01/2019